Intrexon Corp (XON) Q4 2018 Earnings Conference Call February 28, 2019 5:30 PM ET Company Participants Steven Harasym - VP of IR Joel Liffmann - SVP of Finance Bob Walsh - SVP of Energy and Fine Chemicals Nir Nimrodi - Chief Business Officer Thomas Bostick - COO R.J. Kirk - CEO Conference Call Participants Jason Butler - JMP securities Derik De Bruin - Bank of America Operator Good day everyone, and welcome to the Intrexon Fourth Quarter 2018 Financial Results Conference Call. [Operator Instructions] I woul ...

| --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | Precigen Company Update | | | | | | | Helen Sabzevari, PhD President, Precigen | | | | | | | 9 January 2019 JP Morgan 37th Annual Healthcare Conference | | | | | | | | | | | | | | | | | | | | Forward-looking statements Precigen, Inc. is a subsidiary of Intrexon Corporation (Nasdaq: XON). Some of the statements made in this ...